Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Excilia lotion in male pattern androgenic hair loss
IRCT20210130050179N6Phase 2Completed
- Sponsor
- Zist Orchid Pharmed
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of minoxidil, Oxothiazolidinecarboxylic acid, Glycolic acid and caffeine in androgenetic alopecia (AGA), sponsored by Zist Orchid Pharmed. Primary endpoints: Change in terminal hair count and Change in hair loss over time. Started Feb 2023; status: completed.
02
Drugs
minoxidilOxothiazolidinecarboxylic acidGlycolic acidcaffeine
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on IRCT20210130050179N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210130050179N6.